US 10227312
Glucosylceramide synthase inhibitors for the treatment of diseases
granted A61PA61P13/12A61P25/00
Quick answer
US patent 10227312 (Glucosylceramide synthase inhibitors for the treatment of diseases) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOMARIN PHARMACEUTICAL INC.
- Grant date
- Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P13/12, A61P25/00, A61P29/00, A61P3/04